Exagen Balance Sheet Health
Financial Health criteria checks 6/6
Exagen has a total shareholder equity of $22.7M and total debt of $19.5M, which brings its debt-to-equity ratio to 85.9%. Its total assets and total liabilities are $56.9M and $34.3M respectively.
Key information
85.9%
Debt to equity ratio
US$19.50m
Debt
Interest coverage ratio | n/a |
Cash | US$36.49m |
Equity | US$22.69m |
Total liabilities | US$34.25m |
Total assets | US$56.94m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: E08A's short term assets ($47.8M) exceed its short term liabilities ($11.9M).
Long Term Liabilities: E08A's short term assets ($47.8M) exceed its long term liabilities ($22.3M).
Debt to Equity History and Analysis
Debt Level: E08A has more cash than its total debt.
Reducing Debt: E08A had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: E08A has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: E08A has sufficient cash runway for 2.6 years if free cash flow continues to reduce at historical rates of 25.5% each year.